Home Cart 0 Sign in  

[ CAS No. 17702-88-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 17702-88-4
Chemical Structure| 17702-88-4
Structure of 17702-88-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17702-88-4 ]

Related Doc. of [ 17702-88-4 ]

Alternatived Products of [ 17702-88-4 ]

Product Details of [ 17702-88-4 ]

CAS No. :17702-88-4 MDL No. :MFCD01862887
Formula : C10H21NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :JINGUCXQUOKWKH-UHFFFAOYSA-N
M.W : 187.28 Pubchem ID :307923
Synonyms :

Calculated chemistry of [ 17702-88-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.9
Num. rotatable bonds : 8
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 54.66
TPSA : 63.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.0 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.05
Log Po/w (XLOGP3) : 0.63
Log Po/w (WLOGP) : 2.15
Log Po/w (MLOGP) : -0.52
Log Po/w (SILICOS-IT) : 1.68
Consensus Log Po/w : 1.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.87
Solubility : 25.3 mg/ml ; 0.135 mol/l
Class : Very soluble
Log S (Ali) : -1.53
Solubility : 5.47 mg/ml ; 0.0292 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.17
Solubility : 1.28 mg/ml ; 0.00682 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.13

Safety of [ 17702-88-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 17702-88-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17702-88-4 ]
  • Downstream synthetic route of [ 17702-88-4 ]

[ 17702-88-4 ] Synthesis Path-Upstream   1~18

  • 1
  • [ 5440-55-1 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 452
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 452
[3] Journal of Organic Chemistry, 1979, vol. 44, p. 3063 - 3065
[4] Liebigs Annalen der Chemie, 1990, # 12, p. 1175 - 1183
[5] Agricultural and Biological Chemistry, 1982, vol. 46, # 9, p. 2319 - 2324
[6] Helvetica Chimica Acta, 1997, vol. 80, # 4, p. 1280 - 1300
[7] Patent: WO2006/45119, 2006, A2, . Location in patent: Page/Page column 61-62
  • 2
  • [ 773837-37-9 ]
  • [ 124-19-6 ]
  • [ 17702-88-4 ]
YieldReaction ConditionsOperation in experiment
0.487 g
Stage #1: With ammonium chloride In 1,2-dimethoxyethane; water at 50℃; for 20 h; Autoclave
Stage #2: at 40℃; for 6 h;
General procedure: Following the typical procedure described above, Rh(acac)(CO)2 (2.6 mg, 0.01 mmol), xantphos (28.9 mg, 0.05 mmol) were placed in the autoclave. Then a solution of olefin (5 mmol) in DME (8 mL) was added via cannula, the autoclave was pressurized with 20 bar of CO/H2 equimolar mixture and the reaction was conducted for 18 h, upon stirring, at 80°C. After this period, the reactor was cooled to room temperature, an aqueous solution (2 mL) of NH4Cl (5.5 mmol) and NaCN (5.5 mmol) was added via inlet cannula and the reaction was kept at 50°C for 20 h. After work-up and purification, the resulting α-aminonitrile (4.1 mmol) was suspended in a concentrated HCl solution and stirred for 6 h at 40°C. The product was dissolved in methanol. After adjustment of the pH to the isoelectric point, using NH4OH (aq), the solvent was evaporated and the amino acid was obtained.
Reference: [1] Tetrahedron, 2017, vol. 73, # 17, p. 2389 - 2395
  • 3
  • [ 2623-95-2 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1989, vol. 32, # 2, p. 289 - 297
[2] Journal of Biological Chemistry, 1953, vol. 203, p. 333,334
[3] Bl.Nagoya Inst.Technol., 1954, vol. 6, p. 271,273[4] Chem.Abstr., 1956, p. 11943
[5] Journal of Biological Chemistry, 1953, vol. 203, p. 333,334
[6] Bl.Nagoya Inst.Technol., 1954, vol. 6, p. 271,273[7] Chem.Abstr., 1956, p. 11943
[8] Patent: US2109929, 1937, ,
  • 4
  • [ 111-83-1 ]
  • [ 1068-90-2 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 14, p. 5146 - 5151
[2] Journal of the American Chemical Society, 2000, vol. 122, # 17, p. 4032 - 4038
  • 5
  • [ 70562-45-7 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of Organic Chemistry, 1979, vol. 44, p. 3063 - 3065
  • 6
  • [ 629-27-6 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 452
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 452
[3] Journal of Organic Chemistry, 1976, vol. 41, # 21, p. 3491 - 3493
  • 7
  • [ 855212-43-0 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 452
[2] Journal of the American Chemical Society, 1946, vol. 68, p. 452
  • 8
  • [ 111-83-1 ]
  • [ 17702-88-4 ]
Reference: [1] Tetrahedron Letters, 1982, vol. 23, # 41, p. 4255 - 4258
[2] Liebigs Annalen der Chemie, 1990, # 12, p. 1175 - 1183
  • 9
  • [ 111-66-0 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the Chemical Society, Chemical Communications, 1985, # 17, p. 1168 - 1169
[2] Tetrahedron, 2017, vol. 73, # 17, p. 2389 - 2395
[3] Tetrahedron, 2017, vol. 73, # 17, p. 2389 - 2395
  • 10
  • [ 334-48-5 ]
  • [ 17702-88-4 ]
Reference: [1] Patent: US2109929, 1937, ,
[2] Journal of Biological Chemistry, 1953, vol. 203, p. 333,334
  • 11
  • [ 124-19-6 ]
  • [ 17702-88-4 ]
Reference: [1] Tetrahedron, 2017, vol. 73, # 17, p. 2389 - 2395
  • 12
  • [ 60930-31-6 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of Organic Chemistry, 1976, vol. 41, # 21, p. 3491 - 3493
  • 13
  • [ 113889-70-6 ]
  • [ 17702-88-4 ]
Reference: [1] Tetrahedron Letters, 1982, vol. 23, # 41, p. 4255 - 4258
  • 14
  • [ 112-29-8 ]
  • [ 1068-90-2 ]
  • [ 17702-88-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 14, p. 4775 - 4780
  • 15
  • [ 124-19-6 ]
  • [ 74-90-8 ]
  • [ 17702-88-4 ]
Reference: [1] Nippon Nogei Kagaku Kaishi, 1935, vol. 11, p. 712[2] Chem.Abstr., 1935, p. 7279
  • 16
  • [ 111-83-1 ]
  • [ 6326-44-9 ]
  • [ 17702-88-4 ]
Reference: [1] Nagasaki med.J., 1954, vol. 29, p. 385
  • 17
  • [ 7647-01-0 ]
  • [ 5440-55-1 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 452
  • 18
  • [ 5440-55-1 ]
  • [ 10035-10-6 ]
  • [ 17702-88-4 ]
Reference: [1] Journal of the American Chemical Society, 1946, vol. 68, p. 452
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 17702-88-4 ]

Amino Acid Derivatives

Chemical Structure| 5408-52-6

[ 5408-52-6 ]

(S)-2,6-Diaminohexanoic acid (S)-2-aminopentanedioic acid salt

Similarity: 1.00

Chemical Structure| 1313054-79-3

[ 1313054-79-3 ]

(R)-2-Aminoundecanoic acid

Similarity: 1.00

Chemical Structure| 5440-35-7

[ 5440-35-7 ]

2-Aminononanoic acid

Similarity: 1.00

Chemical Structure| 81177-55-1

[ 81177-55-1 ]

(R)-2-Aminononanoic acid

Similarity: 1.00

Chemical Structure| 123225-52-5

[ 123225-52-5 ]

2-Aminoundecanoic acid

Similarity: 1.00